Background: Hybrid brain computer interfaces (BCIs) combining multiple brain imaging modalities have been proposed recently to boost the performance of single modality BCIs.
New Method: In this paper, we propose a novel motor imagery (MI) hybrid BCI that uses electrical brain activity recorded using Electroencephalography (EEG) as well as cerebral blood flow velocity measured using functional transcranial Doppler ultrasound (fTCD). Features derived from the power spectrum for both EEG and fTCD signals were calculated. Mutual information and linear support vector machines (SVM) were employed for feature selection and classification.
Results: Using the EEG-fTCD combination, average accuracies of 88.33%, 89.48%, and 82.38% were achieved for right arm MI versus baseline, left arm MI versus baseline, and right arm MI versus left arm MI respectively. Compared to performance measures obtained using EEG only, the hybrid system provided significant improvement in terms of accuracy by 4.48%, 5.36%, and 4.76% respectively. In addition, average transmission rates of 4.17, 5.45, and 10.57 bits/min were achieved for right arm MI versus baseline, left arm MI versus baseline, and right arm MI versus left arm MI respectively.
Comparison With Existing Methods: Compared to EEG-fNIRS hybrid BCIs in literature, we achieved similar or higher accuracies with shorter task duration.
Conclusions: The proposed hybrid system is a promising candidate for real-time BCI applications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jneumeth.2018.11.017 | DOI Listing |
J Nucl Med
January 2025
Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Lu-DOTATATE has emerged as a viable treatment strategy for advanced well-differentiated grade 1/2 gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Few retrospective studies have shown concomitant Lu-DOTATATE with radiosensitizing low-dose capecitabine to be effective in advanced NETs. However, this has not been validated in prospective randomized-controlled trials.
View Article and Find Full Text PDFHand Surg Rehabil
January 2025
Orthopedic Surgery Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Background: Restoring elbow flexion following brachial plexus injury (BPI) is essential for improving arm function and quality of life in adults. This study aimed to compare the efficacy of Oberlin II and intercostal nerve (ICN) neurotization techniques for restoring elbow flexion in adults with upper and middle trunk brachial plexus palsy.
Methods: This prospective study included 36 patients aged 18 to 50 years with traumatic upper and middle trunk brachial plexus palsy.
Eur J Haematol
January 2025
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Introduction: In the OPTIMISMM trial, pomalidomide/bortezomib/dexamethasone (PVd) significantly prolonged median progression-free survival (PFS) versus bortezomib/dexamethasone (Vd) in lenalidomide-exposed relapsed and refractory multiple myeloma (RRMM). We report final overall survival (OS) and updated efficacy analyses.
Methods: Adults with RRMM who had 1-3 prior regimens, including lenalidomide (≥ 2 cycles), were assigned (1:1) to PVd or Vd.
Cochrane Database Syst Rev
January 2025
Department of Health Promotion and Policy, University of Massachusetts, Amherst, MA, USA.
Rationale: There is limited guidance on the best ways to stop using nicotine-containing vapes (otherwise known as e-cigarettes) and ensure long-term abstinence, whilst minimising the risk of tobacco smoking and other unintended consequences. Treatments could include pharmacological interventions, behavioural interventions, or both.
Objectives: To conduct a living systematic review assessing the benefits and harms of interventions to help people stop vaping compared to each other or to placebo or no intervention.
Curr Cardiol Rep
January 2025
Department of Cardiovascular Medicine, Heart Vascular & Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, J2-3, Cleveland, OH, 44195, USA.
Purpose Of Review: We describe the evolution of caval valve implantation (CAVI) as a treatment for severe symptomatic tricuspid regurgitation (TR) in the high surgical risk patient.
Recent Findings: Surgical treatment of severe TR is often limited by the high surgical risk of the patients who tend to develop severe secondary TR. Coaptation, annuloplasty, and orthotopic replacement strategies are all limited by annular and leaflet geometry, prior valve repair, and the presence of cardiac implantable device leads.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!